CHRISTOPHER BOSCHEE: Open Payments
NPI 1295992154 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 17 payments from 10 companies in 2025. Trend: 2023 $27 · 2024 $0 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $67 |
| Novo Nordisk Inc | 4 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| ABBVIE INC. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: EVENITY, CAPLYTA, Ozempic, UBRELVY, JARDIANCE, MOUNJARO, NURTEC ODT, Dexcom G6 Transmitter.
Industry payments across SD — which companies pay providers there.
